Cargando…
Role of hyaluronan in pancreatic cancer biology and therapy: Once again in the spotlight
Pancreatic ductal adenocarcinoma (PDAC) remains the most deadly disease worldwide, with the lowest survival rate among all cancer types. Recent evidence suggests that hyaluronan (HA), a major component of ECM, provides a favorable microenvironment for cancer progression. Pancreatic ductal adenocarci...
Autores principales: | Sato, Norihiro, Kohi, Shiro, Hirata, Keiji, Goggins, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4970823/ https://www.ncbi.nlm.nih.gov/pubmed/26918382 http://dx.doi.org/10.1111/cas.12913 |
Ejemplares similares
-
Hyaluronan activated-metabolism phenotype (HAMP) in pancreatic ductal adenocarcinoma
por: Kudo, Yuzan, et al.
Publicado: (2019) -
Targeting hyaluronan for the treatment of pancreatic ductal adenocarcinoma
por: Sato, Norihiro, et al.
Publicado: (2016) -
Hyaluronan stimulates pancreatic cancer cell motility
por: Cheng, Xiao-Bo, et al.
Publicado: (2015) -
Prognostic and functional role of hyaluronan-binding protein 1 in pancreatic ductal adenocarcinoma
por: Adachi, Yasuhiro, et al.
Publicado: (2022) -
4-Methylumbelliferone inhibits enhanced hyaluronan synthesis and cell migration in pancreatic cancer cells in response to tumor-stromal interactions
por: Cheng, Xiao-Bo, et al.
Publicado: (2018)